An update from Bicycle Therapeutics (BCYC) is now available.
Bicycle Therapeutics plc has fully repaid its $30.0 million debt to Hercules Capital, Inc. ahead of its 2025 maturity date, settling the loan with a $31.9 million payment from its cash reserves. This strategic financial move releases the company from the annual interest rates between 8.05% and 9.05%, and also frees its assets from previously granted security interests. This bold step could signify a strong cash position or shift in fiscal strategy for Bicycle Therapeutics.
Learn more about BCYC stock on TipRanks’ Stock Analysis page.
